Quo vadis?

COVID-19 has had a huge impact on various industries including manufacturing, travel & tourism as well as life sciences and healthcare. When we talk about ‘industries’, inevitably we talk about human lives. Let’s look beyond the immediate […]

Blue Steens in Aug-Sep 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, test kits […]

Plasma vs virus

Convalescent plasma (CP) therapy gained FDA emergency use authorisation (EUA) in August. It appears that this is surrounded by some controversy and suspicion of politicisation. Without getting anywhere near politics here, let’s not forget that health agencies’ […]

Blue Steens in July 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, hydroxychloroquine as […]

It’s not an immunity passport

I have had discussions lately about the perception that an immunity passport is the same as a vaccination passport. This is not so. The choice of words matters! Let’s explore this from a basic immunological perspective.

Blue Steens in June 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, we’ve seen […]

Convalescent plasma chained

Last month I wrote about being a mentor for one of the teams at the Stop COVID-19 hackathon by ConsenSys Health. My team was called dPlasma and amazingly won the first prize in the competition! ? Let’s […]

Blue Steens in May 2020

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance We’ve seen more reliable COVID-19 serological […]